Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the Treatment of Patients With COVID-19

NCT04547257 is registered in ClinicalTrials.gov with ExThera Medical Corporation as lead sponsor.

NCT NCT04547257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04547257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the Treatment of Patients With COVID-19
Lead sponsor
ExThera Medical Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 4, 2021
Completion date
June 30, 2027
Enrollment
42 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19